OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Allelic Frequency of DPYD Genetic Variants in Patients With Cancer in Spain: The PhotoDPYD Study
Marta Miarons, Alba Manzaneque Gordón, Pau Riera, et al.
The Oncologist (2023) Vol. 28, Iss. 5, pp. e304-e308
Open Access | Times Cited: 9

Showing 9 citing articles:

Balance of care activity after EMA recommendation for DPYD gene testing in Galicia
Almudena Gil-Rodríguez, Sheila Recarey-Rama, Ana Rodríguez-Viyuela, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1

Differences in DPYD Population Frequencies Observed in Galicians Compared to Europeans and Spanish from PhotoDPYD Study
Almudena Gil-Rodríguez, Sheila Recarey-Rama, Ana Rodríguez-Viyuela, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 515-515
Open Access

Diversity of oncopharmacogenetic profile within Spanish population
Irene Ferrer Bolufer, Ximo Galiana-Vallés, Silvia Izquierdo Álvarez, et al.
Pharmacogenetics and Genomics (2024) Vol. 34, Iss. 5, pp. 166-169
Closed Access | Times Cited: 1

Pharmacogenetic‐guided dosing for fluoropyrimidine (DPYD) and irinotecan (UGT1A1*28) chemotherapies for patients with cancer (PACIFICPGx): A multicenter clinical trial
Sarah Glewis, Senthil Lingaratnam, Benjamin Lee, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 12
Closed Access | Times Cited: 1

Implementation of DPYD testing in Bulgarian patients with cancer
Nelly Miteva-Marcheva, Hristo Ivanov, Elena Bangieva-Ivanova, et al.
Biotechnology & Biotechnological Equipment (2024) Vol. 38, Iss. 1
Open Access

Pharmacogenetic DPYD allele variant frequencies: A comprehensive analysis across an ancestrally diverse Iranian population
Negar Sarhangi, Fatemeh Rouhollah, Negar Niknam, et al.
DARU Journal of Pharmaceutical Sciences (2024) Vol. 32, Iss. 2, pp. 715-727
Closed Access

CLINICAL IMPACT OF DPYD GENOTYPING AND DOSE ADJUSTMENT IN CANDIDATES FOR FLUOROPYRIMIDINE TREATMENT
Ana Hernández-Guío, Miguel Ángel Calleja‐Hernández, Andrés Corno-Caparrós, et al.
Heliyon (2024) Vol. 10, Iss. 23, pp. e40808-e40808
Closed Access

Dihydropyrimidine dehydrogenase polymorphisms in patients with gastrointestinal malignancies and their impact on fluoropyrimidine tolerability: Experience from a single Italian institution
Maria D’Amato, Gennaro Iengo, Nicholas Massa, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 17, Iss. 1
Closed Access

Implementation of upfront DPYD genotyping with a low-cost and high-throughput assay to guide fluoropyrimidine treatment in cancer patients
Manuela Pinheiro, Ana Peixoto, Patrícia Rocha, et al.
Pharmacogenetics and Genomics (2023) Vol. 33, Iss. 8, pp. 165-171
Closed Access

Page 1

Scroll to top